
-
2006
Company Description
OrPro Therapeutics develops recombinant thioredoxin for the treatment of cystic fibrosis.
OrPro Therapeutics,Inc. is a pre-‐clinical stage biopharmaceutical company headquartered in San Diego,CA. The company’s goal is to develop a breakthrough class of safe,well-‐tolerated and more effective inhaled non-‐systemic drugs based on the thioredoxin active site for the treatment of patients with cystic fibrosis (CF),COPD/emphysema, bronchiectasis,severe asthma, and other serious obstructive pulmonary diseases.
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Founders:
Peter Heifetz -
Company Website:
-
Company E-mail:
-
Company Address:
12636 HIGH BLUFF DR., SUITE 400San Diego, CAUnited States -
CEO:
- Peter Heifetz
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits